LGVN
Price
$1.61
Change
-$0.04 (-2.42%)
Updated
Apr 29, 10:50 AM (EDT)
Capitalization
24.68M
URGN
Price
$11.08
Change
-$0.18 (-1.60%)
Updated
Apr 29, 11:26 AM (EDT)
Capitalization
519.02M
9 days until earnings call
Ad is loading...

LGVN vs URGN

Header iconLGVN vs URGN Comparison
Open Charts LGVN vs URGNBanner chart's image
Longeveron
Price$1.61
Change-$0.04 (-2.42%)
Volume$248
Capitalization24.68M
UroGen Pharma
Price$11.08
Change-$0.18 (-1.60%)
Volume$700
Capitalization519.02M
LGVN vs URGN Comparison Chart
Loading...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LGVN vs. URGN commentary
Apr 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGVN is a Buy and URGN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 29, 2025
Stock price -- (LGVN: $1.65 vs. URGN: $11.26)
Brand notoriety: LGVN and URGN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGVN: 50% vs. URGN: 455%
Market capitalization -- LGVN: $24.68M vs. URGN: $519.02M
LGVN [@Biotechnology] is valued at $24.68M. URGN’s [@Biotechnology] market capitalization is $519.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $279.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGVN’s FA Score shows that 1 FA rating(s) are green whileURGN’s FA Score has 0 green FA rating(s).

  • LGVN’s FA Score: 1 green, 4 red.
  • URGN’s FA Score: 0 green, 5 red.
According to our system of comparison, LGVN is a better buy in the long-term than URGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGVN’s TA Score shows that 6 TA indicator(s) are bullish while URGN’s TA Score has 5 bullish TA indicator(s).

  • LGVN’s TA Score: 6 bullish, 4 bearish.
  • URGN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than URGN.

Price Growth

LGVN (@Biotechnology) experienced а +8.55% price change this week, while URGN (@Biotechnology) price change was +16.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.10%. For the same industry, the average monthly price growth was -2.09%, and the average quarterly price growth was -11.07%.

Reported Earning Dates

LGVN is expected to report earnings on Feb 28, 2025.

URGN is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+7.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
URGN($519M) has a higher market cap than LGVN($24.7M). URGN YTD gains are higher at: 5.728 vs. LGVN (-4.624). LGVN has higher annual earnings (EBITDA): -15.56M vs. URGN (-110.34M). URGN has more cash in the bank: 237M vs. LGVN (19.2M). LGVN has less debt than URGN: LGVN (1.45M) vs URGN (123M). URGN has higher revenues than LGVN: URGN (90.4M) vs LGVN (2.39M).
LGVNURGNLGVN / URGN
Capitalization24.7M519M5%
EBITDA-15.56M-110.34M14%
Gain YTD-4.6245.728-81%
P/E RatioN/AN/A-
Revenue2.39M90.4M3%
Total Cash19.2M237M8%
Total Debt1.45M123M1%
FUNDAMENTALS RATINGS
URGN: Fundamental Ratings
URGN
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
79
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LGVNURGN
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 5 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
82%
Bullish Trend 15 days ago
82%
Declines
ODDS (%)
Bearish Trend 22 days ago
90%
Bearish Trend 5 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
URGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X94978.7500001223.914100
+1.31%
Bitcoin cryptocurrency
GME27.590.13
+0.47%
GameStop Corp
AAPL210.140.86
+0.41%
Apple
TSLA285.880.93
+0.33%
Tesla
SPY550.850.21
+0.04%
SPDR® S&P 500® ETF

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with URGN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then URGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-5.71%
URGN - LGVN
45%
Loosely correlated
+14.08%
RNA - LGVN
44%
Loosely correlated
+1.18%
BRTX - LGVN
42%
Loosely correlated
-0.58%
CANF - LGVN
34%
Loosely correlated
+1.77%
SNGX - LGVN
31%
Poorly correlated
-4.61%
More

URGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, URGN has been loosely correlated with RNA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if URGN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To URGN
1D Price
Change %
URGN100%
+14.08%
RNA - URGN
51%
Loosely correlated
+1.18%
MREO - URGN
43%
Loosely correlated
+4.40%
LGVN - URGN
43%
Loosely correlated
-5.71%
IDYA - URGN
42%
Loosely correlated
+3.95%
RXRX - URGN
40%
Loosely correlated
+1.92%
More